These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27564673)

  • 1. Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.
    Chiuchiolo MJ; Crystal RG
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4(Suppl 4):S352-69. PubMed ID: 27564673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-1-antitrypsin and other proteinase inhibitors.
    Miravitlles M
    Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin.
    Sosulski ML; Stiles KM; Frenk EZ; Hart FM; Matsumura Y; De BP; Kaminsky SM; Crystal RG
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.
    Mordwinkin NM; Louie SG
    Expert Opin Pharmacother; 2007 Oct; 8(15):2609-14. PubMed ID: 17931094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Alpha-1 Antitrypsin Gene Therapy.
    Lorincz R; Curiel DT
    Am J Respir Cell Mol Biol; 2020 Nov; 63(5):560-570. PubMed ID: 32668173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Placebo-Controlled Trials in Alpha-1 Antitrypsin Deficiency.
    Sandhaus RA
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S370-3. PubMed ID: 27564674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of α1-antitrypsin deficiency.
    Stoller JK; Aboussouan LS
    Am J Respir Crit Care Med; 2012 Feb; 185(3):246-59. PubMed ID: 21960536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of gene therapy for α-1 antitrypsin deficiency.
    Loring HS; Flotte TR
    Expert Opin Biol Ther; 2015 Mar; 15(3):329-36. PubMed ID: 25363251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
    Abboud RT; Ford GT; Chapman KR
    Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of alpha-1 antitrypsin deficiency.
    Ranes J; Stoller JK
    Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy progress and prospects: alpha-1 antitrypsin.
    Stecenko AA; Brigham KL
    Gene Ther; 2003 Jan; 10(2):95-9. PubMed ID: 12571637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.
    Chapman KR; Chorostowska-Wynimko J; Koczulla AR; Ferrarotti I; McElvaney NG
    Int J Chron Obstruct Pulmon Dis; 2018; 13():419-432. PubMed ID: 29430176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
    Tonelli AR; Brantly ML
    Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapleural administration of an AAVrh.10 vector coding for human α1-antitrypsin for the treatment of α1-antitrypsin deficiency.
    Chiuchiolo MJ; Kaminsky SM; Sondhi D; Hackett NR; Rosenberg JB; Frenk EZ; Hwang Y; Van de Graaf BG; Hutt JA; Wang G; Benson J; Crystal RG
    Hum Gene Ther Clin Dev; 2013 Dec; 24(4):161-73. PubMed ID: 24191907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α1-Antitrypsin Deficiency.
    Hatipoğlu U; Stoller JK
    Clin Chest Med; 2016 Sep; 37(3):487-504. PubMed ID: 27514595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches.
    Viglio S; Bak EG; Schouten IGM; Iadarola P; Stolk J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
    Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
    Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency--three-year follow-up.
    Schwaiblmair M; Vogelmeier C; Fruhmann G
    Respiration; 1997; 64(1):10-5. PubMed ID: 9044469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.